Showing results (511-520 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|October 2, 2008
Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancerHaijun Zhong, Yiping Zhang, Shenglin Ma, et al.Anti-Cancer Drugs|June 1, 1991
Selective distribution of aclarubicin to regional lymph nodes with a new dosage form: aclarubicin adsorbed on activated carbon particlesA Hagiwara, T Takahashi, A Iwamoto, et al.Anti-Cancer Drugs|June 1, 1991
Suppressive effect by melatonin on different phases of 9,10-dimethyl-1,2-benzanthracene (DMBA)-induced rat mammary gland carcinogenesisA Subramanian, L KothariAnti-Cancer Drugs|July 3, 2008
Treatment of mucosa-associated lymphoid tissue-type ocular adnexal lymphomaDidier Decaudin, Rémi Dendale, Livia Lumbroso-Le RouicAnti-Cancer Drugs|July 3, 2008
Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cellsMatthew M Roforth, Chalet TanAnti-Cancer Drugs|July 3, 2008
Phase I dose-escalating study of S-1 in combination with oxaliplatin for patients with advanced and/or metastatic colorectal cancerJin Li, Jiliang Yin, Xiaodong Zhu, et al.Anti-Cancer Drugs|September 26, 2007
Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cellsRuo-Kai Lin, Chun-Hua Hsu, Yi-Ching WangAnti-Cancer Drugs|September 26, 2007
An open-labeled phase II trial of docetaxel in combination with cisplatin as first-line cytotoxic therapy for anthracycline-naive patients with metastatic breast cancerYung-Chang Lin, Hsien-Kun Chang, Wen-Chi Shen, et al.Anti-Cancer Drugs|September 26, 2007
Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinomaIoannis Gounaris, Joe Rahamim, Siva Shivasankar, et al.Anti-Cancer Drugs|September 26, 2007
Trastuzumab not for ductal carcinoma in situ?Zeina Nahleh, Azadeh Namakydoust, Rania Bakkar, et al.Pageof 464